Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Pahlman, LA; Hohenberger, WM; Matzel, K; Sugihara, K; Quirke, P; Glimelius, B (2016)
Publisher: American Society of Clinical Oncology
Languages: English
Types: Article
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
    • 2. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345:939-944, 1995
    • 3. Moertel CG, Fleming TR, Macdonald JS, et al: Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 13:2936-2943, 1995
    • 4. Andr e´ T, Boni C, Navarro M, et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009
    • 5. Yothers G, O'Connell MJ, Allegra CJ, et al: Oxaliplatin as adjuvant therapy for colon cancer: Updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29:3768-3774, 2011
    • 6. Schmoll HJ, Tabernero J, Maroun J, et al: Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results of the NO16968 randomized controlled phase III trial. J Clin Oncol 33:3733-3740, 2015
    • 7. Tournigand C, Andre´ T, Bonnetain F, et al: Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: Subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol 30:3353-3360, 2012
    • 8. Heald RJ, Moran BJ, Ryall RD, et al: Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133:894-899, 1998
    • 9. P a˚hlman L, Bohe M, Cedermark B, et al: The Swedish rectal cancer registry. Br J Surg 94:1285-1292, 2007
    • 10. Guren MG, Kørner H, Pfeffer F, et al: Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncol 54:1714-1722, 2015
    • 11. Martling AL, Holm T, Rutqvist LE, et al: Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm: Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 356:93-96, 2000
    • 12. Moriya Y, Hojo K, Sawada T, et al: Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32:307-315, 1989
    • 13. Lange MM, Martz JE, Ramdeen B, et al: Long-term results of rectal cancer surgery with a systematical operative approach. Ann Surg Oncol 20:1806-1815, 2013
    • 14. Hohenberger W, Weber K, Matzel K, et al: Standardized surgery for colonic cancer: Complete mesocolic excision and central ligation-Technical notes and outcome. Colorectal Dis 11:354-364, discussion 364-365, 2009
    • 15. West NP, Kobayashi H, Takahashi K, et al: Understanding optimal colonic cancer surgery: Comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30: 1763-1769, 2012
    • 16. Bertelsen CA, Neuenschwander AU, Jansen JE, et al; Danish Colorectal Cancer Group: Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: A retrospective, population-based study. Lancet Oncol 16:161-168, 2015
    • 17. Kotake K, Mizuguchi T, Moritani K, et al: Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis 29: 847-852, 2014
    • 18. Shimada Y, Hamaguchi T, Mizusawa J, et al: Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205. Eur J Cancer 50:2231-2240, 2014
    • 19. Bernhoff R, Martling A, Sjo¨ vall A, et al: Improved survival after an educational project on colon cancer management in the county of Stockholm: A population based cohort study. Eur J Surg Oncol 41:1479-1484, 2015
    • 20. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 358:1291-1304, 2001
    • 21. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al; Dutch Colorectal Cancer Group: Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. N Engl J Med 345: 638-646, 2001
    • 22. Sebag-Montefiore D, Stephens RJ, Steele R, et al: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 373:811-820, 2009
    • 23. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987, 1997
    • 24. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
    • 25. Sauer R, Liersch T, Merkel S, et al: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926-1933, 2012
    • 26. B o¨ckelman C, Engelmann BE, Kaprio T, et al: Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol 54:5-16, 2015
    • 27. Figueredo A, Coombes ME, Mukherjee S: Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 3: CD005390, 2008
    • 28. Gill S, Loprinzi CL, Sargent DJ, et al: Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 22:1797-1806, 2004
    • 29. Mols F, Beijers T, Lemmens V, et al: Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: Results from the population-based PROFILES registry. J Clin Oncol 31: 2699-2707, 2013 DOI: 10.1200/JCO.2015.65.3048; published online ahead of print at www.jco.org on February 22, 2016.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • No similar publications.

Share - Bookmark

Cite this article